High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
Gespeichert in:
Veröffentlicht in: | British journal of haematology 2013-07, Vol.162 (2), p.282-285 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 285 |
---|---|
container_issue | 2 |
container_start_page | 282 |
container_title | British journal of haematology |
container_volume | 162 |
creator | Liberante, Fabio G. Pellagatti, Andrea Boncheva, Viktoriya Bowen, David T. Mills, Ken I. Boultwood, Jacqueline Guinn, Barbara‐Ann |
description | |
doi_str_mv | 10.1111/bjh.12352 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1381099266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1381099266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3902-900c49b0c5b9fada9b8fa59486c19c64ed1b40a888a6dcdf0ae36bb99a82f5513</originalsourceid><addsrcrecordid>eNp1kM9u1DAQhy0EokvhwAsgX5BAalo7_xofS9WyoCIQgnM0diati2OnHi8lz9CXxu0ucGIuPsznb2Z-jL2U4lDmOtLXV4eyrJryEVvJqm2KUtbyMVsJIY4LKepujz0juhZCVqKRT9leZlUt2nLF7tb28oqDH7gLtwdcbxL3IXHrE8YJBwsJD_iXryefzjj-miMS2eC5w5_oiENEPocQ-RzDpQ-UrOETxB8YKRv4tKALw0Kzg4cWLX6IYUIOiQ-WECh_z0r0CVLWPmdPRnCEL3bvPvt-fvbtdF1cfH7_4fTkojCVEmWhhDC10sI0Wo0wgNLdCPmerjVSmbbGQepaQNd10A5mGAVg1WqtFHTl2DSy2mdvtt689s0GKfWTJYPOgcewoV5WnRRKlW2b0bdb1MRAFHHs52jziUsvRX-ffZ-z7x-yz-yrnXajc3R_yT9hZ-D1DgAy4MYI3lj6xx03shT1_X5HW-7WOlz-P7F_93G9Hf0bquidZg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1381099266</pqid></control><display><type>article</type><title>High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Liberante, Fabio G. ; Pellagatti, Andrea ; Boncheva, Viktoriya ; Bowen, David T. ; Mills, Ken I. ; Boultwood, Jacqueline ; Guinn, Barbara‐Ann</creator><creatorcontrib>Liberante, Fabio G. ; Pellagatti, Andrea ; Boncheva, Viktoriya ; Bowen, David T. ; Mills, Ken I. ; Boultwood, Jacqueline ; Guinn, Barbara‐Ann</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.12352</identifier><identifier>PMID: 23594062</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford: Blackwell</publisher><subject>Antigens, Neoplasm - biosynthesis ; Antigens, Neoplasm - genetics ; Antigens, Neoplasm - metabolism ; Biological and medical sciences ; Biomarkers, Tumor - biosynthesis ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Gene Expression Profiling ; Hematologic and hematopoietic diseases ; Humans ; Kaplan-Meier Estimate ; leukaemia antigens ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; myelodysplastic syndrome ; Myelodysplastic Syndromes - genetics ; Myelodysplastic Syndromes - metabolism ; PReferentially expressed Antigen of the Melanoma Gene ; survival ; Tumors ; tumour antigens</subject><ispartof>British journal of haematology, 2013-07, Vol.162 (2), p.282-285</ispartof><rights>2013 John Wiley & Sons Ltd</rights><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3902-900c49b0c5b9fada9b8fa59486c19c64ed1b40a888a6dcdf0ae36bb99a82f5513</citedby><cites>FETCH-LOGICAL-c3902-900c49b0c5b9fada9b8fa59486c19c64ed1b40a888a6dcdf0ae36bb99a82f5513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.12352$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.12352$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27512041$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23594062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liberante, Fabio G.</creatorcontrib><creatorcontrib>Pellagatti, Andrea</creatorcontrib><creatorcontrib>Boncheva, Viktoriya</creatorcontrib><creatorcontrib>Bowen, David T.</creatorcontrib><creatorcontrib>Mills, Ken I.</creatorcontrib><creatorcontrib>Boultwood, Jacqueline</creatorcontrib><creatorcontrib>Guinn, Barbara‐Ann</creatorcontrib><title>High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>Antigens, Neoplasm - biosynthesis</subject><subject>Antigens, Neoplasm - genetics</subject><subject>Antigens, Neoplasm - metabolism</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - biosynthesis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Gene Expression Profiling</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>leukaemia antigens</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>myelodysplastic syndrome</subject><subject>Myelodysplastic Syndromes - genetics</subject><subject>Myelodysplastic Syndromes - metabolism</subject><subject>PReferentially expressed Antigen of the Melanoma Gene</subject><subject>survival</subject><subject>Tumors</subject><subject>tumour antigens</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9u1DAQhy0EokvhwAsgX5BAalo7_xofS9WyoCIQgnM0diati2OnHi8lz9CXxu0ucGIuPsznb2Z-jL2U4lDmOtLXV4eyrJryEVvJqm2KUtbyMVsJIY4LKepujz0juhZCVqKRT9leZlUt2nLF7tb28oqDH7gLtwdcbxL3IXHrE8YJBwsJD_iXryefzjj-miMS2eC5w5_oiENEPocQ-RzDpQ-UrOETxB8YKRv4tKALw0Kzg4cWLX6IYUIOiQ-WECh_z0r0CVLWPmdPRnCEL3bvPvt-fvbtdF1cfH7_4fTkojCVEmWhhDC10sI0Wo0wgNLdCPmerjVSmbbGQepaQNd10A5mGAVg1WqtFHTl2DSy2mdvtt689s0GKfWTJYPOgcewoV5WnRRKlW2b0bdb1MRAFHHs52jziUsvRX-ffZ-z7x-yz-yrnXajc3R_yT9hZ-D1DgAy4MYI3lj6xx03shT1_X5HW-7WOlz-P7F_93G9Hf0bquidZg</recordid><startdate>201307</startdate><enddate>201307</enddate><creator>Liberante, Fabio G.</creator><creator>Pellagatti, Andrea</creator><creator>Boncheva, Viktoriya</creator><creator>Bowen, David T.</creator><creator>Mills, Ken I.</creator><creator>Boultwood, Jacqueline</creator><creator>Guinn, Barbara‐Ann</creator><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201307</creationdate><title>High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation</title><author>Liberante, Fabio G. ; Pellagatti, Andrea ; Boncheva, Viktoriya ; Bowen, David T. ; Mills, Ken I. ; Boultwood, Jacqueline ; Guinn, Barbara‐Ann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3902-900c49b0c5b9fada9b8fa59486c19c64ed1b40a888a6dcdf0ae36bb99a82f5513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antigens, Neoplasm - biosynthesis</topic><topic>Antigens, Neoplasm - genetics</topic><topic>Antigens, Neoplasm - metabolism</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - biosynthesis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Gene Expression Profiling</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>leukaemia antigens</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>myelodysplastic syndrome</topic><topic>Myelodysplastic Syndromes - genetics</topic><topic>Myelodysplastic Syndromes - metabolism</topic><topic>PReferentially expressed Antigen of the Melanoma Gene</topic><topic>survival</topic><topic>Tumors</topic><topic>tumour antigens</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liberante, Fabio G.</creatorcontrib><creatorcontrib>Pellagatti, Andrea</creatorcontrib><creatorcontrib>Boncheva, Viktoriya</creatorcontrib><creatorcontrib>Bowen, David T.</creatorcontrib><creatorcontrib>Mills, Ken I.</creatorcontrib><creatorcontrib>Boultwood, Jacqueline</creatorcontrib><creatorcontrib>Guinn, Barbara‐Ann</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liberante, Fabio G.</au><au>Pellagatti, Andrea</au><au>Boncheva, Viktoriya</au><au>Bowen, David T.</au><au>Mills, Ken I.</au><au>Boultwood, Jacqueline</au><au>Guinn, Barbara‐Ann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2013-07</date><risdate>2013</risdate><volume>162</volume><issue>2</issue><spage>282</spage><epage>285</epage><pages>282-285</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><cop>Oxford</cop><pub>Blackwell</pub><pmid>23594062</pmid><doi>10.1111/bjh.12352</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1048 |
ispartof | British journal of haematology, 2013-07, Vol.162 (2), p.282-285 |
issn | 0007-1048 1365-2141 |
language | eng |
recordid | cdi_proquest_miscellaneous_1381099266 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content |
subjects | Antigens, Neoplasm - biosynthesis Antigens, Neoplasm - genetics Antigens, Neoplasm - metabolism Biological and medical sciences Biomarkers, Tumor - biosynthesis Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Gene Expression Profiling Hematologic and hematopoietic diseases Humans Kaplan-Meier Estimate leukaemia antigens Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences myelodysplastic syndrome Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - metabolism PReferentially expressed Antigen of the Melanoma Gene survival Tumors tumour antigens |
title | High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A19%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20and%20low,%20but%20not%20intermediate,%20PRAME%20expression%20levels%20are%20poor%20prognostic%20markers%20in%20myelodysplastic%20syndrome%20at%20disease%20presentation&rft.jtitle=British%20journal%20of%20haematology&rft.au=Liberante,%20Fabio%20G.&rft.date=2013-07&rft.volume=162&rft.issue=2&rft.spage=282&rft.epage=285&rft.pages=282-285&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/bjh.12352&rft_dat=%3Cproquest_cross%3E1381099266%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1381099266&rft_id=info:pmid/23594062&rfr_iscdi=true |